In brief

BMJ 2001; 322 doi: (Published 24 February 2001) Cite this as: BMJ 2001;322:448

Paroxetine licensed for post-traumatic stress disorder: Paroxetine, made by GlaxoSmithKline, has been licensed by the UK Medicines Control Agency as a treatment for post-traumatic stress disorder. The drug, which is a selective serotonin reuptake inhibitor, is already licensed for depression, panic, social phobia, and obsessive-compulsive disorder.

India attacks House of Lords judgment on ayurvedic …

View Full Text

Log in

Log in through your institution


* For online subscription